Athira Pharma - ACT-AD Trial

This business has been verified by the owner or a representative.

This business has not yet been verified by the owner or a representative.

Verify this business or learn more about the benefits of verifying.

Unverified
Medical Research
Verify this business

Or click here to see other similar verified businesses in your area.

Contact Information

About

Are You or Someone You Know Living with Alzheimer’s Disease? Consider Participating in the ACT-AD Trial. ACT-AD is a Phase 2 Study of an Investigational Drug for the Treatment of Mild to Moderate Alzheimer’s Disease. The ACT-AD trial is evaluating if a new investigational drug (ATH-1017) is safe and effective in improving symptoms of mild to moderate Alzheimer’s disease. ATH-1017 is designed to boost a repair and regenerative pathway for brain cells, promoting brain health and function. ATH-1017 represents a new approach to treat Alzheimer’s disease, potentially targeting the root cause of memory decline by repairing brain cells and rebuilding brain networks.

Last print ad

Ad promo image large